Darvocet, Darvon Suits Must Be Nixed After Mensing: Lilly

Law360, New York (November 22, 2011, 3:56 PM EST) -- Eli Lilly & Co. asked a Kentucky federal judge Tuesday to dismiss 22 consolidated suits claiming it hid health risks tied to painkillers Darvocet and Darvon, saying consumers' claims are preempted in light of the U.S. Supreme Court's ruling in Pliva v. Mensing.

Consumers' suits, which were consolidated into multidistrict litigation in August, allege Lilly, Xanodyne Pharmaceuticals Inc. and their affiliates and distributors failed to address cardiac risks tied to the drugs, which contain propoxyphene. Some consumers suffered heart attacks after taking the drugs, the suits...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.